Jason E Zucker, MD

Specialties:
Infectious Disease
Accepting New Patients

Overview

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

180 Fort Washington Avenue
Floor 6
New York, NY 10032

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • POS
  • PPO
  • Select Care (Exchange)

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Board Certifications

  • Infectious Disease

Research

Selected Publications

  1. Zucker J, Carnevale C, Gordon P, Sobieszczyk ME, Rai AJ. Am I Positive? Improving Human Immunodeficiency Virus Testing in the Era of Preexposure Prophylaxis and Immediate Antiretroviral Therapy Using Machine Learning. Open Forum Infect Dis. 2022;9(7):ofac259. Published 2022 May 18. doi:10.1093/ofid/ofac259
  2. Cohall A, Cohall R, Rais M, et al. Implementing an STI screening initiative in New York City community colleges [published online ahead of print, 2022 May 27]. J Am Coll Health. 2022;1-7. doi:10.1080/07448481.2022.2068018
  3. Carnevale C, Zucker J, LaSota E, et al. PreexposureProphylaxis at School-Based Health Centers: Awareness and Interest in Starting Preexposure Prophylaxis While Attending a School-Based Health Center in New York City. J Pediatr Health Care. 2022;36(3):256-263. doi:10.1016/j.pedhc.2021.10.006
  4. Rowe K, Theodore DA, Zucker J, et al. Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City. AIDS Patient Care STDS. 2022;36(4):153-158. doi:10.1089/apc.2022.0004
  5. Zucker J, Purpura L, Sani F, et al. Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department. AIDS Patient Care STDS. 2022;36(3):106-114. doi:10.1089/apc.2021.0225
  6. Zucker J, Carnevale C, Theodore DA, et al. Attitudes and Perceived Barriers to Sexually Transmitted Infection Screening Among Graduate Medical Trainees. Sex Transm Dis. 2021;48(10):e149-e152. doi:10.1097/OLQ.0000000000001396
  7. Zucker J, Carnevale C, Theodore D, et al. Attitudes and Perceived Barriers to Routine HIV Screening and Provision and Linkage of Postexposure Prophylaxis and Pre-Exposure Prophylaxis Among Graduate Medical Trainees. AIDS Patient Care STDS. 2021;35(5):180-187. doi:10.1089/apc.2021.0029
  8. Carnevale C, Richards P, Cohall R, et al. At-Home Testing for Sexually Transmitted Infections During the COVID-19 Pandemic. Sex Transm Dis. 2021;48(1):e11-e14. doi:10.1097/OLQ.0000000000001313
  9. Yumori C, Zucker J, Theodore D, et al. Women Are Less Likely to Be Tested for HIV or Offered Preexposure Prophylaxis at the Time of Sexually Transmitted Infection Diagnosis. Sex Transm Dis. 2021;48(1):32-36. doi:10.1097/OLQ.0000000000001265
  10. Nagendra G, Carnevale C, Neu N, Cohall A, Zucker J. The Potential Impact and Availability of Sexual Health Services During the COVID-19 Pandemic. Sex Transm Dis. 2020;47(7):434-436. doi:10.1097/OLQ.0000000000001198
  11. Liu C, Lee J, Ta C, et al. Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis. JMIR Public Health Surveill. 2022;8(5):e35311. Published 2022 May 24. doi:10.2196/35311
  12. Satlin MJ, Zucker J, Baer BR, et al. Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City. PLoS One. 2021;16(11):e0257979. Published 2021 Nov 19. doi:10.1371/journal.pone.0257979
  13. Miller EH, Annavajhala MK, Chong AM, et al. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19. Microbiol Spectr. 2021;9(2):e0005521. doi:10.1128/Spectrum.00055-21
  14. Annavajhala MK, Mohri H, Wang P, et al. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021;597(7878):703-708. doi:10.1038/s41586-021-03908-2
  15. Zucker J, Gomez-Simmonds A, Purpura LJ, et al. Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City. J Clin Med. 2021;10(16):3523. Published 2021 Aug 11. doi:10.3390/jcm10163523
  16. Miller EH, Zucker J, Castor D, et al. Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality. Open Forum Infect Dis. 2021;8(2):ofab003. Published 2021 Jan 4. doi:10.1093/ofid/ofab003
  17. Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020;382(25):2411-2418. doi:10.1056/NEJMoa2012410